Altman Peter

Executive buyer

Director, President and CEO · BioCardia, Inc.

Every open-market stock purchase Altman Peter has reported to the SEC on Form 4 that met our signal bar, parsed straight from the filings. This page tracks where how the prices paid compare to where the stock trades now.

Total bought
$31.6K
Open-market buys
15
Companies
1
Last buy
Oct 16, 2026

Where the buys stand today

All reported buys

DateTickerSharesPriceValueFiling
Oct 16, 2026300$0.95$285.0SEC ↗
Oct 15, 2026200$0.95$190.0SEC ↗
Sep 29, 20261,000$1.03$1.0KSEC ↗
Sep 23, 20261,900$1.05$2.0KSEC ↗
Sep 3, 2026800$1.09$872.0SEC ↗
Aug 17, 20265,400$0.93$5.0KSEC ↗
Aug 13, 20261,900$0.92$1.7KSEC ↗
Jul 29, 20265,000$0.78$3.9KSEC ↗
Jul 17, 2026500$0.83$415.0SEC ↗
Jul 15, 20261,500$0.86$1.3KSEC ↗
Jul 14, 20262,800$0.88$2.5KSEC ↗
Jul 10, 20261,000$0.94$940.0SEC ↗
Jul 9, 20261,000$0.90$900.0SEC ↗
Jul 8, 20265,500$0.97$5.3KSEC ↗
Jul 8, 20265,400$0.96$5.2KSEC ↗

Follow new qualifying clusters involving Altman Peter or other insiders

Explore qualifying clusters from public SEC filings. Pro adds email and Telegram notifications after detection.

About this data

Figures are parsed from Altman Peter's Form 4 filings on SEC EDGAR (CIK 1647542) and cover open-market purchases (transaction code P) — grants, option exercises, and sales are excluded, which is why totals here can differ from raw filing counts. Every row links to its source document.

This page is informational and reflects public filing data. It is not investment advice.